Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial to evaluate safety, tolerability and pharmacokinetic profile of TQC3302 inhalation spray in healthy adult subjects; study is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• TQC3302 inhalation spray (TQC3302)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1 | Status: RECRUITING